Xinqiao Hospital of Chongqing
Chongqing, 400000, China
NCT Number: NCT04347369
The research aim to collect large samples of COVID-19 disease patients with clinical symptoms, laboratory and imaging examination data. Screening the biological indicators which are related to the occurrence of severe diseases. Then, investigators using artificial intelligence (AI) technology deep learning method to find a prediction model that can dynamically quantify COVID-19 disease severity.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Chongqing, 400000, China
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
clinical diagnosis
Time frame: up to 3 months
The performance of our prediction model is evaluated with the receiver operating characteristic (ROC) curves, areas under the curves (AUCs) and concordance index (c-index).
Time frame: up to 3 months
The calibration curves analysis is used to show error between the predicted clinical phenotype with prediction model and actual clinical phenotype.
Time frame: up to 3 months
Decision curve analysis was used to determine whether the models could be considered useful tools for clinical decisionmaking by comparing the net benefits at any threshold.
Xinqiao Hospital of Chongqing
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04587323
COVID-19, COVID-19 Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05329220
COVID-19 Disease
Birmingham, Alabama, United States
View Trial DetailsNCT04830800
COVID-19, COVID-19 Disease
Hanoi, Vietnam
View Trial DetailsNCT04472013
COVID-19 Disease
Basel, Switzerland
View Trial Details